President and CEO of Alexza Pharmaceuticals Inc. Thomas Braxton King Bought 40,000 Shares
On July 26, 2013, Pres & CEO of Alexza Pharmaceuticals Inc. (ALXA) Thomas Braxton King bought 40,000 shares of ALXA stock at an average price of $4.48. The total transaction amount was $179,200
Thomas B. King has been the President, CEO and member of Board of Alexza Pharmaceuticals since June 2003. Prior to joining this company, King served at Cognetix Inc. as CEO, president and a member of the board. He has also worked at Anesta Corporation and Cephalon Inc.
Alexza Pharmaceuticals Inc. reported its 2013 first financial quarter results. The company announced net loss of $20.7 million and revenues of $729,000.